AEON Biopharma, Inc. (AEON)
Largest Insider Buys in Sector
AEON Stock Price History Chart
AEON Stock Performance
About AEON Biopharma, Inc.
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Insider Activity of AEON Biopharma, Inc.
Over the last 12 months, insiders at AEON Biopharma, Inc. have bought $0 and sold $0 worth of AEON Biopharma, Inc. stock.
On average, over the past 5 years, insiders at AEON Biopharma, Inc. have bought $0 and sold $38.29M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, AEON Biopharma, Inc.
| 2023-08-11 | Sale | 10 percent owner | 7.38M – | $10.00 | $73.8M | -21.15% | ||
| 2021-03-23 | Sale | 10 percent owner | 73,226 3.4019% | $10.10 | $739,583 | |||
| 2021-03-22 | Sale | 10 percent owner | 100,650 4.6993% | $10.15 | $1.02M | |||
| 2021-03-19 | Sale | 10 percent owner | 11,033 0.5176% | $10.20 | $112,537 | |||
| 2021-03-17 | Sale | 10 percent owner | 3,500 0.1642% | $10.20 | $35,700 | |||
| 2021-02-25 | Sale | 10 percent owner | 62,356 2.9686% | $10.35 | $645,385 | |||
| 2021-02-17 | Sale | 10 percent owner | 10,000 0.4899% | $10.65 | $106,500 | |||
| 2021-01-26 | Sale | 10 percent owner | 10,000 0.483% | $10.50 | $105,000 |